Abstract:BACKGROUND:Methotrexate (MTX) is an antiproliferative drug widely used to treat inflammatory diseases and autoimmune diseases. The application of percutaneous administration is hindered due to its poor transdermal penetration. To reduce side effects and enhanced percutaneous delivery of MTX, novel methotrexate (MTX)-loaded micelles prepared with a amphiphilic cationic material, N,N-dimethyl-(N',N'-di-stearoyl-1-ethyl)1,3-diaminopropane (DMSAP), was designed.MATERIALS AND METHODS:DMSAP was synthesized via three steps using simple chemical agents. H nuclear magnetic resonance and mass spectroscopy were used to confirm the successful synthesis of DMSAP. A safe and non-toxic phosphatidylcholine, soybean phosphatidylcholine (SPC), was added to DMSAP at different ratios to form P/D-micelles. Then, MTX-entrapped micelles (M/P/D-micelles) were prepared by electrostatic adsorption. The physicochemical properties and blood stability of micelles were examined thoroughly. In addition, the transdermal potential of the micelles was evaluated by permeation experiments.RESULTS:In aqueous environments, DMSAP conjugates could self-assemble spontaneously into micelles with a low critical micelle concentration (CMC) of 0.056 mg/mL. Stable, spherical MTX-entrapped micelles (M/P/D-micelles) with a size of 100-120 nm and high zeta potential of +36.26 mV were prepared. In vitro permeation studies showed that M/P/D-micelles exhibited superior skin permeability and deposition of MTX in the epidermis and dermis compared with that of free MTX.CONCLUSION:These special novel cationic M/P/D-micelles can enhance the permeability of MTX and are expected to be a promising percutaneous delivery system for therapy skin diseases.

Poly(ethylene Oxide)‐graft‐methotrexate Macromolecular Drugs Conjugating Via Aminopteridine Ring Exhibit Potent Anticancer Activity

Enhanced Percutaneous Delivery of Methotrexate Using Micelles Prepared with Novel Cationic Amphipathic Material

Preparation and Antitumor Activity of a Polymeric Derivative of Methotrexate

Methotrexate-conjugated to polymer quantum dot for cytotoxicity effect improved against MCF-7 and Hela cells

Synthesis and in vitro evaluation of methotrexate conjugated O,N-carboxymethyl chitosan via peptidyl spacers

Preparation and in Vitro Release of Methotrexate Complexation with PEGylated Dendrimers

PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents

Preparation and Characterization of PEGylated Poly-L-Lysine-Hydroxycamptothecin Nanoparticles Without and with Methotrexate

Functionalized Magnetic Fe3O4 Nanoparticles for Targeted Methotrexate Delivery in Ovarian Cancer Therapy

Water-soluble poly(ethylene glycol) prodrug of pemetrexed: Synthesis, characterization, and preliminary cytotoxicity

Enhanced Antitumor Efficacy by Methotrexate Conjugated Pluronic Mixed Micelles Against Kbv Multidrug Resistant Cancer

The Therapeutic Effect of Methotrexate-Conjugated Pluronic-Based Polymeric Micelles on the Folate Receptor-Rich Tumors Treatment

PEGylated PAMAM Dendrimers As a Potential Drug Delivery Carrier:In Vitroandin Vivocomparative Evaluation of Covalently Conjugated Drug and Noncovalent Drug Inclusion Complex

In situ grafting of PEG Acrylate on drugs with aliphatic hydroxyl functionalities via RAFT polymerization to synthesize drug/polymer conjugates with improved water solubility

Isomeric Folate-Conjugated Polymeric Micelles Bind to Folate Receptors and Display Anticancer Effects.

Pluronic Mixed Micelles Overcoming Methotrexate Multidrug Resistance: in Vitro and in Vivo Evaluation.

Poloxamer 407 based-nanoparticles for controlled release of methotrexate

Dynamic methotrexate nano-prodrugs with detachable PEGylation for highly selective synergistic chemotherapy

Synthesis and Biological Properties of Ferrocenyl and Organic Methotrexate Derivatives

Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.

Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer